This summer we discussed the great corporate support pivot that was required due to the pandemic. Since then, we’ve had to respond to a vicious third wave of the pandemic, the election of a new president… and a promising outlook for vaccines in 2021. Where does this leave our corporate support efforts? More importantly, how should we assess our own business models going forward? Join us for a follow-up conversation with Paul Jacobs, vice president…